{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:28:12Z","timestamp":1790641692490,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:00:00Z","timestamp":1503532800000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD047315), United States"],"award-info":[{"award-number":["HD047315), United States"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian National Health and Medical Research Council","award":["349301"],"award-info":[{"award-number":["349301"]}]},{"DOI":"10.13039\/100009898","name":"DHA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.plefa.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T20:48:41Z","timestamp":1471985321000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials"],"prefix":"10.1016","volume":"112","author":[{"given":"L.N.","family":"Yelland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Gajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Makrides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2016.08.007_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.1989.tb01454.x","article-title":"Pregnancy duration and the ratio of long-chain n-3 fatty acids to arachidonic acid in erythrocytes from Faroese women","volume":"731","author":"Olsen","year":"1989","journal-title":"J. Intern. Med. Suppl."},{"key":"10.1016\/j.plefa.2016.08.007_bib2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0140-6736(92)90533-9","article-title":"Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration","volume":"339","author":"Olsen","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.plefa.2016.08.007_bib3","first-page":"Cd003402","article-title":"Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction","author":"Makrides","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.plefa.2016.08.007_bib4","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.2010.1507","article-title":"Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial","volume":"304","author":"Makrides","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.plefa.2016.08.007_bib5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3945\/ajcn.112.050021","article-title":"DHA supplementation and pregnancy outcomes","volume":"97","author":"Carlson","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2016.08.007_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0035-1571199","article-title":"A worldwide epidemic: the problem and challenges of preterm birth in low- and middle-income countries","volume":"33","author":"Smid","year":"2016","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.plefa.2016.08.007_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19466315.2015.1133453","article-title":"Commensurate priors on a finite mixture model for incorporating repository data in clinical trials","volume":"8","author":"Gajewski","year":"2016","journal-title":"Stat. Biopharm. Res."},{"key":"10.1016\/j.plefa.2016.08.007_bib8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/sim.3900","article-title":"Joint Bayesian analysis of birthweight and censored gestational age using finite mixture models","volume":"29","author":"Schwartz","year":"2010","journal-title":"Stat. Med."},{"key":"10.1016\/j.plefa.2016.08.007_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1214\/12-BA722","article-title":"Commensurate priors for incorporating historical information in\u00a0clinical trials using general and generalized linear models","volume":"7","author":"Hobbs","year":"2012","journal-title":"Bayesian Anal."},{"key":"10.1016\/j.plefa.2016.08.007_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1475-2891-13-31","article-title":"U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008","volume":"13","author":"Papanikolaou","year":"2014","journal-title":"Nutr. J."},{"key":"10.1016\/j.plefa.2016.08.007_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.ejcn.1601344","article-title":"Discrepancies in dietary intakes and plasma concentrations of fatty acids according to age among Japanese female dietitians","volume":"56","author":"Kuriki","year":"2002","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2016.08.007_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejogrb.2015.11.033","article-title":"Effects of omega-3 fatty acids in prevention of early preterm delivery: a systematic review and meta-analysis of randomized studies","volume":"198","author":"Kar","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.plefa.2016.08.007_bib13","unstructured":"P. Middleton, E. Shepherd, J. Gould, S. Olsen, L. Duley, M. Makrides Omega-3 supplementation during pregnancy, Cochrane Database of Cochrane Reviews, 2016 (in press)."},{"key":"10.1016\/j.plefa.2016.08.007_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.plefa.2015.08.002","article-title":"Analysis of hospital cost outcome of DHA-rich fish-oil supplementation in pregnancy: evidence from a randomized controlled trial","volume":"102\u2013103","author":"Ahmed","year":"2015","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.plefa.2016.08.007_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.plefa.2016.05.008","article-title":"Docosahexaenoic acid supplementation (DHA) and the return on investment for pregnancy outcomes","volume":"111","author":"Shireman","year":"2016","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327816300655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327816300655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:05:03Z","timestamp":1760601903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327816300655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":15,"alternative-id":["S0952327816300655"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2016.08.007","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}